pfizer-signs on, page-60

Lets look at who RHT are working with across several projects: Glaxo Smith Kline, Pfizer, Novartis. These are truly global names. There must be something in their technology to attract company's of this calibre. I have made a couple of phone calls to the company this week and am impressed with the MD. What I need to do now is get a better understanding of the short, medium and long term growth prospects and the timeline to achieve it. Then I can start to put a valuation on RHT. However I already know enough to conclude that it is much higher than 3 cents, hence my purchase for the medium term.